Name: Tyrosine-protein kinase CSK Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Tyrosine-protein kinase CSK Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	Saracatinib	IC50	840.0 ^[1]
	Ibrutinib	IC50	2.2 ^[1]
	7-[cis-4-(4-Methylpiperazin-1-Yl)cyclohexyl]-5-(4-Phenoxyphenyl)-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine	IC50	41.0 ^[1], 4270.0 ^[2]
	2-PropenaMide, N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl]-	IC50	2.4 ^[1]
	Tofacitinib	IC50	10000.0 ^[1]
Rows per page: 1–5 of 100

References

This online resource may be cited as follows

MLA	"Quest Database™ Tyrosine-protein kinase CSK Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-csk-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 20). Quest Database™ Tyrosine-protein kinase CSK Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-csk-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan